Cargando…
A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs
We present a sarcoma patient with a tumor reduction of more than 50% in lung metastasis after 2 single courses of the investigational medical product Lutathera ((177)Lu-DOTA0-Tyr3-octreotate). She was resistant to more than 6 lines of therapy including all the available active drugs in soft tissue s...
Autores principales: | Crespo-Jara, Aurora, González Manzano, Ramón, Lopera Sierra, Maribel, Redal Peña, María Carmen, Brugarolas Masllorens, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979627/ https://www.ncbi.nlm.nih.gov/pubmed/27355848 http://dx.doi.org/10.1097/RLU.0000000000001288 |
Ejemplares similares
-
Metastatic Insulinoma Managed with Radiolabeled Somatostatin Analog
por: Costa, Ricardo, et al.
Publicado: (2013) -
Somatostatin Receptor Scintigraphy in a Patient with Myocarditis
por: Amini, Abdullatif, et al.
Publicado: (2021) -
A novel genomic signature predicting FDG uptake in diverse metastatic tumors
por: Crespo-Jara, Aurora, et al.
Publicado: (2018) -
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
por: Eychenne, Romain, et al.
Publicado: (2020) -
Metastatic Malignant Paraganglioma Presenting as a Neck Mass Treated with Radiolabeled Somatostatin Analog
por: Jehangir, Waqas, et al.
Publicado: (2021)